Search

everythinglearnresearchcommunity

for

Search:↓

CD28 is a promising target for treating alopecia areata with belatacept.

CD28 is a promising target for treating alopecia areata with belatacept.

Tofacitinib regrew hair in a man with total hair loss but raised cytokine levels, needing more research on possible side effects.

Trastuzumab deruxtecan is effective for HER2-positive breast cancer but requires careful management of side effects.

Laser-pretreated blood for hair loss treatment was more effective and increased stem cells.

Myeloid-derived suppressor cells help control autoimmune cells and promote hair regrowth in alopecia areata.

TSC2-/meth cells can cause skin lesions, hair growth, and lung issues, and may be treated with chromatin remodeling agents.

CD10 helps distinguish between basal cell carcinoma and benign hair follicle tumors.

ABCG2 protein marks stem-like skin cells in human epidermis.

2h-ICPR can help screen for insulin antibodies in type 2 diabetes patients.

Gamma/delta T cells help defend skin against heavy metals.

Combined therapy reduces inflammation and restores immune balance in alopecia areata patients.

Autoimmune reactions may cause both alopecia areata and HAM.

CD8+ virtual memory T cells may cause hair loss in alopecia areata.

Merkel cell carcinoma is most likely to recur within two years of diagnosis, and factors like immune suppression, being over 75, and male sex increase this risk.

Oral valganciclovir improved a patient's skin condition caused by immunosuppression.

Certain NK cell changes in blood may indicate alopecia areata progression.

CD34 is crucial for skin tumor development in mice.

Blocking the CXCR3 receptor reduces T cell accumulation in the skin and prevents hair loss in mice.

Raltitrexed conjugates are less potent than the free drug but more effective at high concentrations.

Bendamustine combined with tucidinostat may effectively treat adult T-cell leukemia.

CD34 is absent in most basal cell carcinoma cells but present in surrounding skin.

Some patients developed hair loss after islet cell transplant possibly due to their immune-suppressing medications.

Gene knockout mice developed scars similar to human hypertrophic scars, useful for studying scar progression.

Transglutaminase-3 is often reduced in esophageal cancer.

Trodelvy™ helped some patients with advanced breast cancer, but had side effects.

Using the drugs AMD3100 and Tacrolimus together greatly improves skin healing and hair growth after a deep skin cut by increasing stem cells in the wound.

3D spheroid culture makes stem cells better at reducing inflammation.

Certain immune markers may predict chemotherapy response in mesothelioma, and nivolumab is a tolerable and effective treatment for advanced non-small cell lung cancer.

Combining UVB irradiation and anti-CD154 antibody improves hair follicle transplant survival.